International Stem Cell Corp. (ISCO.OB) Teams with Cytograft to Develop a Method to Cultivate Living Human Grafts
Biotechnology company International Stem Cell Corp. (OTCBB: ISCO) is recognized as the first company to successfully create a human “parthenogenetic”…